SC 13G/A filed Nov 4, 2026 at 16:04 ET
BlackRock filed an amended Schedule 13G disclosing beneficial ownership of 19,373,309 shares of BioMarin common stock, representing 10.0% of shares outstanding as of October 31, 2026. This is an increase from the prior filing (Vanguard's April 2026 filing showed 18,549,911 shares at 10.0%), indicating BlackRock added approximately 823,398 shares. The filing is a routine passive stake update by a large index/asset manager, filed two days after BioMarin reported Q3 revenue up 32% YoY but lowered full-year guidance.